Skip to main content
Premium Trial:

Request an Annual Quote

Jean-Michel Cossery, Michael Jones, Martha Trela, TLV Kumar, David Bailey, Sigma-Aldrich, Oxford Gene Technology, SciGene


People in the News

GE Healthcare announced new positions for two officers last week.

Chief marketing officer Jean-Michel Cossery is now also vice-president, GE said. He had served as executive vice-president of global marketing at Amersham Health since 2000, and joined GE Healthcare after GE acquired Amersham in 2004.

Cossery has five post graduate degrees, including an MBA from the Rotterdam School of Management. He received a PhD in pharmacology and a PhD in nuclear chemistry and neurology from the University of Paris in 1987 and 1986, respectively. He received his MSc in organic chemistry in 1984 and in pharmacy in 1983, also from the University of Paris.

Michael Jones is now vice-president, business development. He has been a general manager at GE since 1998. Prior to joining GE, Jones spent 10 years on Wall Street in a variety of M&A, private equity and investment banking roles.

Martha Trela has left Affymetrix according to a company spokesperson. Trela formerly served as vice president of commercial marketing at Affy.

Prior to joining Affymetrix, Trela served as vice president of worldwide marketing programs and communications at Applied Biosystems.

TLV Kumar has been appointed president of the Asia-Pacific operations at Applied Biosystems, ABI's parent company Applera said last week.

Kumar comes to ABI from Philips Medical Systems, where he was chief operations officer for Asia Pacific.

Genome Alberta's board of directors recently appointed David Bailey as its new president and CEO.

Bailey was a research scientist with Agriculture and Agri-Food Canada before becoming research center director and director general.

Bailey obtained his PhD in genetics and animal breeding at the University of Alberta in 1985.


New Product Watch

Sigma-Aldrich this week launched its Panorama Signal Transduction Functional Protein Array for high-throughput functional screening. The company recommends using the array for monitoring cellular response to external or internal stimuli.

The array uses a fusion tag to confer protein functionality and serves to select, tether, and uniformly orientate proteins on a streptavidin-coated glass slide, and enables the high-throughput analysis against 259 human cell signaling proteins, Sigma-Aldrich said. The array was co-developed with Procognia.

The analysis system includes buffers and software, according to the company.

Oxford Gene Technology last week launched its OGT Chip2 Escherichia coli K12 microarray for chromatin immunoprecipitation (ChIP)-on-chip applications.

OGT said that the chip is fabricated using OGT's ink-jet in situ synthesis platform and interrogates the whole E. coli K-12 genome with a probe density of 22,000 oligonucleotide features.

SciGene last week introduced its Hybex Microarray Incubation System.

According to the company, the Hybex System consists of a small benchtop heating unit with two removable chambers that hold specially designed racks for incubating up to 16 DNA, protein, or tissue arrays at one time.

Arrays remain in the racks after incubation for washing and staining, SciGene said.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.